Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer-Reference-Cited by-同舟云学术

Randomised study of two doses of cisplatin with cyclophosphamide in epithelial ovarian cancer

Published:1992-08 Issue:8815 Volume:340 Page:329-333
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Kaye S.B.,Lewis C.R.,Paul J.,Soukop M.,Rankin E.M.,Cassidy J.,Davis J.A.,Reed N.S.,MacLean A.,Kennedy J.H.,Symonds R.P.,Duncan I.D.,Gordon H.K.,Kitchener H.C.,Cruickshank D.J.,Swapp G.A.,Sarkar T.K.,Atkinson R.J.,Crawford S.M.

Publisher

Elsevier BV

Subject

General Medicine

Reference24 articles.

1. High-dose cisplatin compared with high-dose cyclophosphamide in the management of advanced epithelial ovarian cancer (FIGO stages III and IV): report from the North Thames Cooperative Group;Lambert;BMJ,1985

2. Controversy over combination chemotherapy in advanced ovarian cancer: what we learn from reports of matured data;Dembo;J Clin Oncol,1986

3. Randomised trial in advanced ovarian cancer comparing cisplatin and carboplatin;Mangioni;J Natl Cancer Inst,1989

4. Randomized trial comparing chemotherapy regimens (CHAP-5 vs CP) in advanced ovarian carcinoma;Neijt;J Clin Oncol,1987

5. Dose intensity analysis of chemotherapy regimens in ovarian carcinoma;Levin;J Clin Oncol,1987

Cited by 181 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Human Ovarian Tumor & Liver Organ-on-Chip for Simultaneous and More Predictive Toxo-Efficacy Assays;Bioengineering;2023-02-18

2. Anaemia and pathologic complete response rate according to carboplatin dose in HER2 + breast cancer treated with neoadjuvant TCHP;Cancer Medicine;2022-07-15

3. The Role of Tumour Metabolism in Cisplatin Resistance;Frontiers in Molecular Biosciences;2021-06-23

4. Trial-level analysis of progression-free survival and response rate as end points of trials of first-line chemotherapy in advanced ovarian cancer;Medical Oncology;2017-04-08

5. The impact of the National Institute for Health Research Health Technology Assessment programme, 2003–13: a multimethod evaluation;Health Technology Assessment;2015-08